These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 8918691)
1. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis. Szeliga J; Hess H; Rüde E; Schmitt E; Germann T Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response. Mauri C; Feldmann M; Williams RO Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis. Germann T; Hess H; Szeliga J; Rüde E Ann N Y Acad Sci; 1996 Oct; 795():227-40. PubMed ID: 8958934 [TBL] [Abstract][Full Text] [Related]
4. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen. Stasiuk LM; Abehsira-Amar O; Fournier C Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886 [TBL] [Abstract][Full Text] [Related]
5. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065 [TBL] [Abstract][Full Text] [Related]
6. Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice. Anthony DD; Heeger PS; Haqqi TM Clin Exp Rheumatol; 2001; 19(4):385-94. PubMed ID: 11491493 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Germann T; Bongartz M; Dlugonska H; Hess H; Schmitt E; Kolbe L; Kölsch E; Podlaski FJ; Gately MK; Rüde E Eur J Immunol; 1995 Mar; 25(3):823-9. PubMed ID: 7705414 [TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Kato I; Endo-Tanaka K; Yokokura T Life Sci; 1998; 63(8):635-44. PubMed ID: 9718093 [TBL] [Abstract][Full Text] [Related]
9. Identification of a cyanogen bromide fragment of porcine type II collagen capable of modulating collagen arthritis in B10.RIII (H-2r) mice. Nabozny GH; Griffiths MM; Harper DS; Luthra HS; David CS Autoimmunity; 1995; 20(1):39-49. PubMed ID: 7578860 [TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. Watson WC; Townes AS J Exp Med; 1985 Dec; 162(6):1878-91. PubMed ID: 3934318 [TBL] [Abstract][Full Text] [Related]
11. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice. Kai H; Shibuya K; Wang Y; Kameta H; Kameyama T; Tahara-Hanaoka S; Miyamoto A; Honda S; Matsumoto I; Koyama A; Sumida T; Shibuya A Immunology; 2006 Jun; 118(2):233-9. PubMed ID: 16771858 [TBL] [Abstract][Full Text] [Related]
12. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846 [TBL] [Abstract][Full Text] [Related]
13. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma. Tellander AC; Michaëlsson E; Brunmark C; Andersson M J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055 [TBL] [Abstract][Full Text] [Related]
14. Suppression of murine collagen-induced arthritis by nasal administration of collagen. Myers LK; Seyer JM; Stuart JM; Kang AH Immunology; 1997 Feb; 90(2):161-4. PubMed ID: 9135541 [TBL] [Abstract][Full Text] [Related]
15. Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis. van Vollenhoven RF; Nagler-Anderson C; Soriano A; Siskind GW; Thorbecke GJ Cell Immunol; 1988 Aug; 115(1):146-55. PubMed ID: 3401929 [TBL] [Abstract][Full Text] [Related]
16. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is associated with anti-CII B-cell activation. Holmdahl R; Vingsbo C; Malmström V; Jansson L; Holmdahl M J Autoimmun; 1994 Dec; 7(6):739-52. PubMed ID: 7888032 [TBL] [Abstract][Full Text] [Related]
17. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267 [TBL] [Abstract][Full Text] [Related]
18. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498 [TBL] [Abstract][Full Text] [Related]
19. Intranasal administration of denatured type II collagen and its fragments can delay the onset of collagen-induced arthritis. Matsumoto T; Ametani A; Hachimura S; Iwaya A; Taguchi Y; Fujita K; Shigehisa T; Kaminogawa S Clin Immunol Immunopathol; 1998 Jul; 88(1):70-9. PubMed ID: 9683552 [TBL] [Abstract][Full Text] [Related]
20. CD28-deficient mice are highly resistant to collagen-induced arthritis. Tada Y; Nagasawa K; Ho A; Morito F; Ushiyama O; Suzuki N; Ohta H; Mak TW J Immunol; 1999 Jan; 162(1):203-8. PubMed ID: 9886387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]